Business Insider22d
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
These injections work by mimicking hormones ... at a significantly lower cost — around $250 to $350 per month for tirzepatide, compared to Zepbound's list price of $1,059. With the official ...
People20d
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version
"FDA has determined that the shortage of tirzepatide injection products ... People can get prescriptions through telehealth, and the cost is lower than traditional prescriptions not covered ...
Zepbound can now be covered by Medicare
El Lilly’s (LLY) blockbuster weight-loss drug Zepbound is now eligible for Medicare coverage. The news could significantly ...
Everyday Health24d
FDA Says Shortages of GLP-1 Drugs Mounjaro and Zepbound Are Over
Without insurance, prefilled injection pens with Zepbound and Mounjaro cost about $1,000 a month. Copycats have been selling for much less. For example, Hims & Hers offered compounded tirzepatide ...
JD Supra12d
FDA Announced Removal of Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...
Ask a Health Professional: How do semaglutide and tirzepatide support wellness goals?
Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...
Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'
Eli Lilly moves to defend FDA's tirzepatide shortage resolution amid criticism over supply issues and compounding pharmacy claims.